BC3 Technologies Announces First Retail Availability of SEAL Hemostatic Wound Spray at Army & Air Force Exchange Service Locations
BC3 Technologies' FDA-cleared SEAL Hemostatic Wound Spray is now available at 77 Army & Air Force Exchange Service locations across the U.S. and overseas, marking the product's first brick-and-mortar retail rollout. Acme United (NYSE American: ACU) is fulfilling the rollout by leveraging its existing First Aid Only distribution relationship, which already supplies SEAL to industrial, government, and educational customers.
Key figures
- Rollout start
- August 10, 2026
- Aafes locations
- 77
- Hsa fsa eligible
- Yes
- Regulatory status
- FDA-cleared
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.